Mutations or dysregulation of CHMP4B have been associated with various diseases, including neurodegenerative disorders like frontotemporal dementia (FTD) and Alzheimer's disease (AD) 69, 70. Here, CHMP4B is linked to early-onset autosomal dominant Alzheimer disease.